arrow
返回
T

Thomas Powles

Queen Mary University of London

77H指数
688论文数
3.7W被引数
收录论文 195
发表时间
66 Relationship Between Health-related Quality of Life and Efficacy in the Phase 3 LITESPARK-005 Study of Belzutifan versus Everolimus in Previously Treated Advanced Clear Cell Renal Cell Carcinoma66 健康相关生活质量与疗效在LITESPARK-005研究(比较Belzutifan与Everolimus在先前治疗过的晚期透明细胞肾细胞癌中的效果)第三阶段的关系
err2026-09-02
err0
errOAAI
errPooja Ghatalia; Thomas B Powles; Laurence Albiges; Katriina Peltola; Guillermo de Velasco; Mauricio Burotto; Cristina Suarez; Elaine T Lam; Roberto Iacovelli; Mahmut Gumus; Elena Verzoni; Christian Kollmannsberger; Walter M Stadler; Reshma Shinde; Todd L Saretsky; Li He; Donna Vickery; Toni K Choueiri; Brian Rini
err分享
err收藏
4 Baseline and Early On-Treatment Plasma Kidney Injury Molecule-1 (KIM-1) Levels are Associated with Outcomes in Advanced Renal Cell Carcinoma (aRCC)基线和早期治疗期间血浆肾损伤分子-1(KIM-1)水平与晚期肾细胞癌(aRCC)患者的预后相关
err2026-09-02
err0
errOAAI
errWenxin Xu; Habib Hamidi; Robert J Motzer; Thomas Powles; Laurence Albiges; Marc Machaalani; Svetlana Andrianova; Saurabh Gupta; Venu Valmeekam; Toni K Choueiri; Bradley A McGregor; Andrew Simmons
err分享
err收藏
1 Pembrolizumab Plus Belzutifan Versus Pembrolizumab Plus Placebo as Adjuvant Therapy for Renal Cell Carcinoma: Patient-Reported Outcomes in LITESPARK-0221 帕博利珠单抗联合贝舒妥昔单抗与帕博利珠单抗联合安慰剂作为肾细胞癌辅助治疗:LITESPARK-022研究中的患者报告结局
err2026-09-02
err0
errOAAI
errThomas B Powles; Toni K Choueiri; Jose A Karam; Cristina Suarez; Wesley Yip; Rana R McKay; Thomas Ferguson; Pooja Ghatalia; Christian Caglevic; Jad Chahoud; Roberto Iacovelli; Hans Hammers; Carlos Rojas; Rui Kang; Todd L Saretsky; Manish Sharma; Joseph E Burgents; Robert J Motzer
err分享
err收藏
20 PF-08634404 (SSGJ-707), a Tetravalent PD-1/VEGF Bispecific Antibody for the Treatment of Renal Cell Carcinoma (NCT07227415)20 PF-08634404 (SSGJ-707),一种四价PD-1/VEGF双特异性抗体,用于治疗肾细胞癌(NCT07227415)
err2026-09-02
err0
errOAAI
errToni Choueiri; Sumanta Pal; Thomas Powles; Meghan Zuck; Catalina Sakai; Eliana Moskovitz; Laila Shehata; Markus Carlson; Florian Heinkel; Sherif Abdelhamed; Michelle Ulrich; Matthew Rathgeber; Gregory Szeto; Brian O’Connor; Joseph Dekker; Ryan Heiser; Brian Rini
err分享
err收藏
err分享
err收藏
TROPION-Urothelial03: a phase II/III study of datopotamab deruxtecan (Dato-DXd) for locally advanced or metastatic urothelial carcinomaTROPION-Urothelial03:达波替安德鲁克坦(Dato-DXd)治疗局部晚期或转移性尿路上皮癌的II/III期研究
err2026-05-16
err0
PREAI
errMatthew D. Galsky; Alexandra Drakaki; Arnab Basu; Bradley McGregor; Jens Bedke; Yohann Loriot; Eiji Kikuchi; Jun Guo; Benjamin Garmezy; Srikala S. Sridhar; Parminder Singh; Vadim S. Koshkin; Mark Fleming; Gunnar Klauss; Daisy Lin; Chelsea Liu; Andrea B. Apolo; Thomas Powles
err分享
err收藏
A plain language summary of the TROPiCS-04 study: sacituzumab govitecan use after platinum-based chemotherapy and immunotherapy in people with locally advanced or metastatic cancer of the bladder, urethra, or upper urinary tractTROPiCS-04研究的通俗语言摘要:沙西妥珠单抗在铂类化疗和免疫疗法之后,用于患有膀胱、尿道或上尿路局部晚期或转移性癌症的人群
err2025-11-01
err1
PREAI
errPowles, Thomas; Tagawa, Scott T.; Vulsteke, Christof; Gross-Goupil, Marine; Park, Se Hoon; Necchi, Andrea; De Santis, Maria; Duran, Ignacio; Morales-Barrera, Rafael; Guo, Jun; Sternberg, Cora N.; Bellmunt, Joaquim; Goebell, Peter J.; Kovalenko, Maria; Boateng, Freda; Sierecki, Mitch; Wang, Lu; Sima, Camelia S.; Waldes, Jana; Bangs, Rick; Loriot, Yohann; Grivas, Petros
err分享
err收藏
HERTHENA-PanTumor01: a phase II study of patritumab deruxtecan (HER3-DXd) in previously treated advanced solid tumorsHERTHENA-PanTumor01:一项关于帕托珠单抗德鲁克替康(HER3-DXd)在既往治疗过的晚期实体瘤中的II期研究
err2025-10-14
err0
errOAAI
errThomas Powles; Aarti Bhatia; Barbara Burtness; Takahiro Kogawa; Tomohiro Nishina; Izuma Nakayama; Christos Fountzilas; Dani R. Castillo; Meredith McKean; Funda Meric-Bernstam; Nicoletta Colombo; James W. Smithy; Jérome Fayette; Sunandana Chandra; David W. Sternberg; Fan Jin; Kendall Sullivan; Sue Yueh; Graham Clinthorne; Ariel E. Aguilo; Ragini Kudchadkar; Hidetoshi Hayashi
err分享
err收藏
ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder CancerctDNA指导下的辅助阿特珠单抗治疗在肌肉浸润性膀胱癌中的应用
err2025-10-01
err10
PREAI
errPowles, Thomas; Kann, Ariel G.; Castellano, Daniel; Gross-Goupil, Marine; Nishiyama, Hiroyuki; Bracarda, Sergio; Bjerggaard Jensen, Jorgen; Makaroff, Lydia; Jiang, Shusuan; Ku, Ja Hyeon; Park, Se Hoon; Reig Torras, Oscar; Ye, Dingwei; Maruzzo, Marco; Necchi, Andrea; Morales-Barrera, Rafael; Giunta, Emilio Francesco; Lee, Jae Lyun; Tortora, Giampaolo; Urun, Yuksel; Dolowy, Lukasz; Erdem, Dilek; Pinto, Alvaro; Grando, Fabricio; Zou, Wei; Assaf, Zoe June; Vuky, Jacqueline; Degaonkar, Viraj; Steinberg, Elizabeth E.; Bellmunt, Joaquim; Gschwend, Jurgen E.
err分享
err收藏
Real-World evidence shows no survival advantage with contemporary first-line strategies in papillary renal cell carcinoma: a call for randomized trials真实世界证据表明,在乳头状肾细胞癌中,当代一线策略并未显示出生存优势:呼吁开展随机试验
err2025-10-01
err0
errOAAI
errZugman, Miguel; Rider, Jennifer R.; Dizman, Nazli; Jaime-Casas, Salvador; Goes, Vitor Abreu; Shah, Koral; Castro, Daniela, V; Mercier, Benjamin; Zang, Peter; Ebrahimi, Hedyeh; Barragan-Carrillo, Regina; Sahu, Diwyanshu; Mandora, Prithviraj Vikramsinh; Hsu, Joann; Yip, Wesley; Nguyen, Charles B.; Chehrazi-Raffle, Alex; Miller, Robert; Powles, Thomas; Choueiri, Toni; Pal, Sumanta K.
err分享
err收藏
Criteria Used to Determine Platinum Eligibility in Patients with Metastatic Urothelial Carcinoma: Results of a Physician Survey in Five European Countries用于确定转移性尿路上皮癌患者顺铂适用性的标准:来自五个欧洲国家医师调查的结果
err2025-09-23
err0
PREAI
errShilpa Gupta; Thomas Powles; Mairead Kearney; Laura Panattoni; Natalie Land; Thomas Flottemesch; Patrick Sullivan; Melissa Kirker; Murtuza Bharmal; Silke Guenther; Nuno Costa; Enrique Grande
err分享
err收藏
Pembrolizumab plus axitinib versus sunitinib for advanced clear cell renal cell carcinoma: 5-year survival and biomarker analyses of the phase 3 KEYNOTE-426 trial帕博利珠单抗联合阿昔替尼对比舒尼替尼治疗晚期透明细胞肾细胞癌:KEYNOTE-426 III期试验的5年生存率和生物标志物分析
err2025-08-01
err0
errOAAI
errBrian I. Rini; Elizabeth R. Plimack; Viktor Stus; Rustem Gafanov; Tom Waddell; Dmitry Nosov; Frédéric Pouliot; Boris Alekseev; Denis Soulières; Bohuslav Melichar; Ihor Vynnychenko; Sergio Jobim de Azevedo; Delphine Borchiellini; Raymond S. McDermott; Jens Bedke; Satoshi Tamada; Sterling Wu; Julia Markensohn; Yiwei Zhang; Andrey Loboda; Amir Vajdi; Rodolfo F. Perini; Joseph Burgents; Thomas Powles
err分享
err收藏
SGNDV-001: disitamab vedotin with pembrolizumab in HER2-expressing locally advanced or metastatic urothelial carcinomaSGNDV-001: 西迪妥单抗维多汀联合帕博利珠单抗治疗表达HER2的局部晚期或转移性尿路上皮癌
err2025-07-29
err0
errOAAI
errThomas B. Powles; Enrique Grande; Nimira Alimohamed; Niara Oliveira; Srikala S. Sridhar; Alexandra Drakaki; Ravindran Kanesvaran; Yohann Loriot; Andrea Necchi; Sonia Franco; Dingfeng Jiang; Kristel Apolinario; Wei Zhang; Matthew D. Galsky
err分享
err收藏
Author Correction: Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial作者更正: Sasanlimab加BCG在BCG幼稚,高危非肌层浸润性膀胱癌中的应用: 随机3期CREST试验
err2025-07-21
err0
errOAAI
errNeal D. Shore; Thomas B. Powles; Jens Bedke; Matthew D. Galsky; Joan Palou Redorta; Ja Hyeon Ku; Michal Kretkowski; Evanguelos Xylinas; Boris Alekseev; Dingwei Ye; Félix Guerrero-Ramos; Alberto Briganti; Girish S. Kulkarni; Julia Brinkmann; Anna-Maria Calella; Rossano Cesari; Anthony Eccleston; Elisabete Michelon; Jennifer Vermette; Caimiao Wei; Gary D. Steinberg
err分享
err收藏
Enfortumab vedotin plus pembrolizumab in untreated locally advanced or metastatic urothelial carcinoma: 2.5-year median follow-up of the phase III EV-302/KEYNOTE-A39 trial☆恩诺单抗维多汀联合帕博利珠单抗治疗未经治疗的局部晚期或转移性尿路上皮癌:III期EV-302/KEYNOTE-A39试验的中位2.5年随访结果☆
err2025-06-01
err0
PREAI
errT.B. Powles; M.S. Van der Heijden; Y. Loriot; J. Bedke; B.P. Valderrama; G. Iyer; E. Kikuchi; J. Hoffman-Censits; C. Vulsteke; A. Drakaki; S. Rausch; W. Arafat; S.H. Park; U. Swami; J.-R. Li; I. Duran; S. Gorla; B. Homet Moreno; X. Yu; Y.-T. Lu; S. Gupta
err分享
err收藏
Hospital Volume as a Determinant of Outcomes After Partial Nephrectomy: A Systematic Review by the European Association of Urology Renal Cell Carcinoma Guidelines Panel医院手术量作为部分肾切除术预后的决定因素:欧洲泌尿外科学会肾细胞癌指南专家组系统评价
err2025-06-01
err0
PREAI
errLorenzo Marconi; Teele Kuusk; Milan Hora; Tobias Klatte; Saaed Dabestani; Umberto Capitanio; Yasmin Abu-Ghanem; Riccardo Campi; Sergio Fernández-Pello; Laurence Albiges; Jens Bedke; Thomas Powles; Alessandro Volpe; Börje Ljungberg; Axel Bex
err分享
err收藏
Characterization of Patients with Lymph Node Only Metastatic Urothelial Carcinoma Treated with Nivolumab Plus Gemcitabine-Cisplatin Versus Gemcitabine-Cisplatin Alone from the CheckMate 901 TrialCheckMate 901试验中,仅淋巴结转移性尿路上皮癌患者接受纳武利尤单抗联合吉西他滨-顺铂治疗与单独吉西他滨-顺铂治疗的特征分析
err2025-05-20
err0
errOAAI
errMatthew D. Galsky; Michiel S. van der Heijden; Thomas Powles; Melanie Claps; Mauricio Burotto; Michael Schenker; Juan Pablo Sade; Aristotelis Bamias; Philippe Beuzeboc; Jens Bedke; Jan Oldenburg; Yüksel Ürün; Dingwei Ye; Begoña P. Valderrama; Yoshihiko Tomita; Ruiyun Jiang; Jeiry Filian; Lily Wang; Maximiliano van Kooten Losio; Guru Sonpavde
err分享
err收藏